-
Trump denies offering to sell arms to China's Xi
-
Justice Alito steps aside from major US climate case
-
Wemby ready for NBA Spurs to move rivals in climb to top
-
Willis happy with England exile after retains Top 14 player award
-
Ukraine to postpone some spending amid delays in aid: PM
-
Spain housing protests keep heat on government as PM seeks new law
-
Tuchel says Czech Republic game 'not yet a must-win'
-
Wissa spoils Zimbabwe homecoming as DR Congo win AFCON qualifier
-
MaXhosa puts South Africa on the Paris fashion map
-
UK police release on bail five men held over airbase incident
-
Rose, Scott among 2027 World Golf Hall of Fame finalists
-
Ex-All Black Plummer 'sure' New Zealand will find Super Rugby solution
-
Brunson says NBA champion Knicks can't get satisfaction
-
Shein sees 1% revenue growth in first half of 2026
-
France puts out largest wildfire since 1949
-
Netherlands regrets Israel retaliation in settlements row
-
Real Madrid's Perez summoned over Barcelona referee payments comments
-
Moscow seizes Russian assets of German food retailer Metro
-
Oil takes off again, Wall Street dips after Trump rejects Iran truce offer
-
Bulgarian spirits inflamed by new rakia rules
-
AlgoQuant Asset Management Selects Liquid Mercury to Enhance Digital Asset Trading Infrastructure
-
Documentary turns camera on architect Peter Zumthor
-
UK to reopen refugee resettlement scheme to push 'safe' migration
-
UK police say releasing on bail five men held over airbase incident
-
Pope urges Europe to help combat 'lies and deceit' in world affairs
-
Trump admin finalizes reversal of US fuel economy standards
-
Iranian lawyer Nasrin Sotoudeh wins Council of Europe's rights prize
-
US says no China arms sale plans after envoy cites Trump offer
-
French far-right's Bardella denies alleged 2013 antisemitic comments
-
Dozens kidnapped in two weekend attacks in northern Nigeria
-
Oil up, Wall Street dips after Trump rejects Iran truce offer
-
Next stop the world: Pathirage wins Asian Games javelin gold
-
Gakpo withdraws from Netherlands squad
-
Aster Launches Perpetual Grid Trading 2.0 with Up to 140,000 $ASTER Liquidity Mining Campaign
-
SpaceX puts Starship megarocket in orbit for first time
-
Seoul says North Korean mines 'highly suspected' as cause of DMZ blast
-
Iran denies link to suspected bomb plot at UK airbase used by US
-
Russia pummels Kyiv in latest deadly daytime attack
-
Ex-boss Mancini says City charges 'not my concern'
-
Wartime Ukraine works to keep its railways on track
-
Berlin Marathon winner Assefa finished race with torn Achilles
-
Boy among 3 dead in migrant Channel crossing accident: French authorities
-
Comedian convicted for Erdogan 'insult' but freed pending appeal
-
SGFX Creates a Standout Brand Experience at Forex Expo Dubai 2026
-
French prosecutors seek two-year sentence for ex-minister Dati in graft case
-
Pope urges Europe to help combat 'deceit and lies' in international ties
-
Eala makes fast start as weather and transport woes hit Asian Games
-
Injured Buttler to miss England ODI series in Pakistan
-
Hurricane Polo approaches Mexico, threatens severe damage
-
Madrid housing protesters vow to maintain pressure on government
Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
J.AbuHassan--SF-PST